Our Annual International Conference for Alzheimer’s Drug Discovery, held in September, focuses on the discovery and development of drugs targeting Alzheimer’s disease and related dementias. The Drug Discovery for Neurodegeneration: An Intensive Course on Translating Research into Drugs, held in February, is designed to educate scientists on the process of translating basic neuroscience research into innovative therapies.
The ADDF also plans smaller “catalyst conferences” that center around a relevant topic in the field of neurodegeneration. A list of our upcoming conferences is available here.
We encourage corporations, foundations and individuals to co-sponsor our international scientific conferences to advance Alzheimer’s drug discovery.
Co-sponsorship offers the opportunity to learn about the latest research in the field as well as unique licensing and partnering opportunities for early-stage programs. Co-sponsors are recognized in all conference-related materials and the ADDF Annual Highlights. Co-sponsors may also be eligible for display space and conference bag inclusion